• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The relationship between DOAC levels and clinical outcomes: The measures tell the tale-Response from original authors Lijfering et al.

作者信息

Toorop Myrthe M A, Scheres Luuk J J, Lijfering Willem M

机构信息

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

出版信息

J Thromb Haemost. 2021 Apr;19(4):1136-1138. doi: 10.1111/jth.15248.

DOI:10.1111/jth.15248
PMID:33792178
Abstract
摘要

相似文献

1
The relationship between DOAC levels and clinical outcomes: The measures tell the tale-Response from original authors Lijfering et al.直接口服抗凝剂（DOAC）水平与临床结局之间的关系：这些指标说明了问题——原作者利费林等人的回应
J Thromb Haemost. 2021 Apr;19(4):1136-1138. doi: 10.1111/jth.15248.
2
Comment on the article by Toorop et al.: "The relationship between DOAC levels and clinical outcomes: The measures tell the tale".对图罗普等人文章的评论：“直接口服抗凝剂水平与临床结局的关系：指标说明一切”
J Thromb Haemost. 2021 Apr;19(4):1134-1136. doi: 10.1111/jth.15245.
3
The relationship between DOAC levels and clinical outcomes: The measures tell the tale.直接口服抗凝剂（DOAC）水平与临床结局之间的关系：这些指标说明了情况。
J Thromb Haemost. 2020 Dec;18(12):3163-3168. doi: 10.1111/jth.15104. Epub 2020 Oct 19.
4
Long-Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation.长期服用直接口服抗凝药物的依从性轨迹与房颤患者的临床结局。
J Am Heart Assoc. 2021 Nov 2;10(21):e021601. doi: 10.1161/JAHA.121.021601. Epub 2021 Oct 29.
5
Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.在非瓣膜性心房颤动的心源性栓塞性卒中患者中早期引入直接口服抗凝剂。
J Thromb Thrombolysis. 2016 Oct;42(3):393-8. doi: 10.1007/s11239-016-1393-9.
6
Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation.采用直接口服抗凝剂预防心房颤动中的脑卒中。
Intern Med J. 2016 Jul;46(7):792-7. doi: 10.1111/imj.13088.
7
Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.双腔起搏器和植入式心律转复除颤器指导下基于连续房颤负荷监测的间断抗凝治疗：来自非持续房颤个体化抗凝治疗（TACTIC-AF）试验的研究结果。
Heart Rhythm. 2018 Nov;15(11):1601-1607. doi: 10.1016/j.hrthm.2018.06.027. Epub 2018 Jul 6.
8
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.非瓣膜性心房颤动瑞典患者不依从直接口服抗凝剂的影响：来自真实世界成本效用分析的结果。
J Med Econ. 2022 Jan-Dec;25(1):1085-1091. doi: 10.1080/13696998.2022.2116848.
9
In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.美国房颤抗凝时代华法林和直接口服抗凝剂致心肌梗死患者院内出血结局：来自全国心血管数据注册急性冠脉治疗和干预结局网络注册的报告。
J Am Heart Assoc. 2019 Apr 16;8(8):e011606. doi: 10.1161/JAHA.118.011606.
10
Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation.临床医生和患者对直接口服抗凝剂用于房颤的使用和剂量的偏好差异。
J Am Heart Assoc. 2021 Jun;10(11):e020697. doi: 10.1161/JAHA.120.020697. Epub 2021 May 15.

引用本文的文献

1
The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization.DOAC 检测背后的误区：来自不同监管机构的说明书分析及实现统一化的呼吁
J Thromb Haemost. 2022 Nov;20(11):2494-2506. doi: 10.1111/jth.15884. Epub 2022 Oct 13.